drugset / Trial / NCT06750757

Intraoperative Bone Marrow Aspirate Concentrate Injections: Evaluating Outcomes in a Randomized Controlled Trial

NCT06750757

Phase 4 Not yet recruiting 80 enrolled American Hip Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to see if bone marrow aspirate concentrate (BMAC) used with your hip arthroscopy surgery is a better treatment than just having surgery alone for treatment of labral tears in your hip. BMAC is an injection, where your doctor will insert a needle into your hip and harvest the bone marrow that is located inside of your bones. This will be performed under anesthesia during your hip arthroscopy surgery and will be injected during the procedure. BMAC is an FDA approved procedure and has had many research articles produced from it. Researchers will compare patients who received BMAC during their surgery to those who have not to determine if the injection with surgery is better than surgery alone.

Timeline

Start
2025-02
Primary completion
2027-02
Completion
2028-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone Marrow Aspirate Concentrate Cell therapy 145 ml Other

Indications

No indication recorded.